VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) — Biologic Pharmamedical™ Research and Manufacturing proudly announces a revolutionary advancement in metabolic health research with its new patent-pending technology, Capryl-Butyrate™. This proprietary molecular complex is set to redefine approaches to managing metabolic syndrome, offering potential solutions to a range of chronic conditions prevalent in North America, including diabetes, cardiovascular and cerebrovascular diseases, obesity, chronic inflammation, cognitive decline, and accelerated aging.
Biologic Pharmamedical™ Reveals Capryl-Butyrate™ and necessary lifestyle changes for natural solutions for Gut Health, Mental Clarity, and Age-Defying Wellness
